Fig. 5

Expression level of six genes and clinicopathological parameters in the risk model. Expression level of 6 genes in TCGA-BRAC, METABRIC, GSE86166 cohorts (a) and in-house cohort (b). The risk score distribution in early- and advanced- breast cancer in TCGA-BRAC cohort (c), METABRIC cohort (e) and GSE86166 cohort (g). The risk score distribution in different subtypes and pathologic stage in TCGA-BRAC cohort (d), METABRIC cohort (f), and GSE86166 cohort (h); *p < 0.05, **p < 0.01; ***p < 0.005, ****p < 0.001, ns, no significance